Han Li
Taiping Street
Luzhou, 646000, China
Luzhou, 646000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications
Interpretable LASSO-Cox model: Hsp90α/albumin ratio predicts hepatocellular carcinoma prognosis.
Journal: Translational cancer research
Published: June 28, 2025
Targeting TBXAS1: a novel target of daidzein in alleviating APAP-induced hepatic injury.
Journal: International immunopharmacology
Published: June 18, 2025
Hic-5 deficiency attenuates MAFLD by inhibiting neutrophils migration via the CXCL1-CXCR2 axis.
Journal: Journal of gastroenterology
Published: March 12, 2025
Machine Learning Radiomics for Predicting Response to MR-Guided Radiotherapy in Unresectable Hepatocellular Carcinoma: A Multicenter Cohort Study.
Journal: Journal of hepatocellular carcinoma
Published: February 07, 2025
ANG secretion predisposes endothelial cells toward angiogenesis in FIN56-induced ferroptotic hepatocellular carcinoma via the BMP6/ID1 signaling pathway.
Journal: Free radical biology & medicine
Published: November 24, 2024
The role of RNA binding proteins in cancer biology: A focus on FMRP.
Journal: Genes & diseases
Published: September 13, 2024
Oncogenic HJURP enhancer promotes the aggressive behavior of triple-negative breast cancer in association with p53/E2F1/FOXM1-axis.
Journal: Cancer letters
Published: August 13, 2024
Stereotactic body radiation therapy (SBRT) increases anti-PD-1 antitumor activity by enhancing the tumor immune microenvironment in mice with metastatic hepatocellular carcinoma.
Journal: Discover oncology
Published: July 28, 2024
Incidence trends, overall survival, and metastasis prediction using multiple machine learning and deep learning techniques in pediatric and adolescent population with osteosarcoma and Ewing's sarcoma: nomogram and webpage.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: July 13, 2024
Efficacy and safety of the combination of envafolimab and lenvatinib in unresectable hepatocellular carcinoma: a single-arm, multicentre, exploratory phase II clinical study.
Journal: Investigational new drugs
Published: July 04, 2024
Construction of an interpretable model for predicting survival outcomes in patients with middle to advanced hepatocellular carcinoma (≥5 cm) using lasso-cox regression.
Journal: Frontiers in pharmacology
Published: June 20, 2024
Last Updated: 09/26/2026